CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Oppose "march-in" rights and "compulsory licensing" proposals Support protection of the Bayh-Dole Act and tech transfer process Oppose policy proposal requiring Access Plans to be part of licensing agreements for NIH owned inventions Support transferable exclusivity extensions to incentivize novel antibiotic and rare disease R&D
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Manufacturing MAN
Support robust domestic supply chain development and manufacturing ecosystem
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Labor Issues/Antitrust/Workplace LBR
Educate policymakers and regulators on the unique role of mergers and acquisitions in the life sciences industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Budget/Appropriations BUD
Support legislation to reform Congressional Budget Office scoring of health care legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Health Issues HCR
Support diversity in clinical trial policy Oppose legislation that expands Medicare Drug Pricing Negotiation Program (MDPNP) Support bipartisan effort to address health care workforce shortage Support incentives for antimicrobial resistance development (PASTEUR Act) Support legislation that applies additional payments, discounts, and other financial assistance towards the cost-sharing requirements of health insurance plans Support legislation to prohibit pharmacy benefit managers (PBMs) from linking rebates paid by manufacturers to the list price of a drug and instead implement a flat service fee paid to PBMs Educate Congress on the current state of artificial intelligence in health care and the current regulatory landscape Support legislation to modernize the U.S. Preventive Services Task Force (USPSTF) Support electronic labeling for all medical devices, regardless of setting of use or the intended user (Medical Device Electronic Labeling Act)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Medicare/Medicaid MMM
Oppose legislative proposal to reform Patent system and Intellectual Property issues impacting the life sciences ecosystem Support capping Medicare beneficiary out of pocket costs Support legislation to expand and clarify the exclusion for orphan drugs under the Medicare Drug Price Negotiation Program Oppose CMS proposed changes to the Medicaid Drug Rebate Program (MDRP) to redefine how Medicaid Best Price is calculated Support improvements to manufacturer and stakeholder input processes within the Medicare Drug Price Negotiation Program Support legislation providing Medicare coverage for anti-obesity medication Support improvements to manufacturer engagement process for Small Biotech Exemption within MDPNP CMS CY2025 Hospital Outpatient Prospective Payment System (OPPS) proposed rule
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Taxation/Internal Revenue Code TAX
Support R&D and NOL tax incentives, Orphan Drug Tax Credits Support legislation to restore the immediate expensing of research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Medical/Disease Research/Clinical Labs MED
Support promulgation of TCET final rule Support breakthrough device coverage bill Support legislation proposing coverage for multicancer screening Support timely reauthorization of the FDA Pediatric Rare Disease Priority Review Voucher program Support robust funding for the NIH in FY2025 appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENTON J. FISK | — |
| ABIGAIL LORE | — |
| ANTHONY THEISSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.